Identifying cardiometabolic syndrome can help your physician customers effectively treat diabetes and cardiovascular disease.
Statistics show that 83 million Americans suffer from cardiovascular disease. Also according to statistics, more than 29 million Americans have diabetes, and one in three Americans may have signs of pre-diabetes. Your physician customers are no doubt aware of those issues within their patient base. What they may not realize is effective treatment with either disease state can best be realized by testing and monitoring for both through recognizing the signs of cardiometabolic syndrome.
Cardiometabolic syndrome is a cluster of conditions — including high blood pressure, high blood sugar levels, high cholesterol, high triglyceride levels, low HDL cholesterol levels, and excess body fat around your waist — which occur together.
If an individual has at least three of these conditions, the patient likely has metabolic syndrome, and the risk of developing cardiovascular disease or diabetes is greatly increased. That means an increased risk of complications, including loss of eyesight and kidney failure from diabetes, and heart attack and stroke from cardiovascular disease.
“With diabetes, we know that you can control the blood sugar and get it back to normal,” says James Anderson, MD, PTS Diagnostics’ Medical Officer. “But those people still have an increased risk of developing cardiovascular complications. Likewise, we know that people with lipid disease have high triglycerides and high cholesterol, and that actually causes insulin resistance, which can be a factor in causing the development of diabetes. So diabetes makes cardiovascular disease worse, and cardiovascular disease makes diabetes worse.”
However, diagnosis and treatment of diabetes and cardiovascular complications have typically been segmented. “You look at the world of medicine and you have diabetologists who deal with diabetes, and you have cardiovascular physicians who deal with heart disease,” says Anderson. “They really ought to be working together very closely. You cannot really separate the two diseases and treat them independently.”
That’s why PTS Diagnostics is encouraging distributor reps to bundle CardioChek® analyzers and A1CNow®+ systems when discussing solutions with their physician customers. Having tests to measure both blood lipids and glucose control allows physicians a more comprehensive picture of a patient’s health. And it gives the physician the results in an optimum window of time to consult their patients.
“Our CardioChek analyzer measures lipids in as little as 90 seconds. The A1CNow+ system provides a result in five minutes. The major advantage is that because you can get the tests done so rapidly, the physician can actually counsel the patient while the patient is still in the exam room,” says Anderson. “The ability to do that has a much greater impact than the patient getting a letter in the mail a few days or a week following the visit saying ‘Your cholesterol or glucose was elevated, you should speak with your physician the next time you see them.’ The impact of immediate counseling is much more forceful and much more effective in dealing with the patient than a delayed education.”
For more information on CardioChek analyzers and A1CNow+ systems, visit ptsdiagnostics.com.
Why Bundle A1CNow+ systems and CardioChek analyzers?
Consider the “ABCs” of cardiometabolic syndrome:
- “A” stands for A1C monitoring.
- “B” stands for blood pressure
- “C” stands for cholesterol levels
PTS Diagnostics’ A1CNow+ systems and CardioChek analyzers help physicians identify patients who are at risk for cardiometabolic syndrome.
A1CNow+ systems
More efficient than the lab
- A1C result in 5 minutes
- Small (5μL) blood sample from fingerstick
- Portable (use in multiple exam rooms)
- Minimal training required
- Reimbursable
CardioChek analyzers
Fast, Accurate Lipid and Glucose Results at the Point of Care
- Full lipid panel and glucose results in as little as 90 seconds
- Fingerstick (40 µL sample size for lipids)
- Portable, handheld, battery-powered
- Wireless Communication
- Reimbursable